- विज्ञापन -
38 medicines including those for diabetes, migraine, high blood pressure, stomach gas, vitamin D-3 and infection manufactured in Himachal Pradesh have not been found to be up to the standards. Migraine medicines are supplied only to government hospitals. Samples of two batches of this have failed. Samples of 135 medicines across the country have been found to be substandard. The Central Drugs Standard Control Organization and the State Drug Controller had taken samples of medicines in December.
State Drug Controller Manish Kapoor said that notices have been issued to the companies whose drug samples have failed and their stock has been recalled. The process of cancelling the license has also been started.
Two samples of Divalproex manufactured at Biodil Pharmaceutical Nalagarh have failed. At the same time, Betahistine of CMG Biotech Kangra, Okamate of Cipla Company Nalagarh, Pentaprazole of Adamed Pharma Baddi, Zinc Sulphate of Orchid Medlife Company Baddi, Amoxicillin of Wedsp Pharmaceutical Jhadmajri, Pantoprazole of Kegen Pharmaceutical Katha, Cefdoxine of Knox Pharmaceutical Baddi, Calcium Carbonate of Medopharma Company Baddi, Cipex-500 of Mewter Biogenesis Makhlumajra, Terbicare-250 of Neptune Lyc Sciences Thana located, Intraconazole, Tuvari-LS of CSD Life Sciences Makhlumajra, Sucrazm-O Suspension of Aces Life Sciences Parwanoo, Iron Sucrose Injection of Effie Peritrial Badudi, Justcof-LS of Ultra Drugs Formulations Company Batudi, Dexamethus-1 of Laborate Pharmaceutical Paonta Sahib Injection, Retrajit-250 of Sefnix Life Sciences Paonta, Brokof-DM medicine samples of CV Healthcare Nalagarh have not been found correct.
Along with this, samples of Temcof-LS syrup of Asterisk Healthcare Company Haroli, mouthwash of Fogon Pharmaceutical Company Barotiwala have failed. Samples of Meropenem Injection-500 of Shamtri Life Sciences Baddi, two batches of Raveprazole injection of Alliance Biotax Katha, Fexofenadine tablet of CMG Biotech Kangra, Raveprazole Sodium injection of Martin & Brown Biosciences Makhlumajra, Lignocani of Genosis Pharmaceutical, two batches of Xbax suspension of Ozone Pharmaceutical Baddi, Noscapine Syrup of Medipol Pharmaceutical Baddi, Telmisartan of Orison Pharma International Kala Amb, Acyclovir tablet of Systol Remdesivir Company, Albendazole tablet of Martin & Brown Company Nalagarh, Botezovib of Medion Private Limited, Pentopazole of Ultra Igs Private Limited, Paracetamol medicine of Lone Healthcare Company have been found to be incorrect.
